Two new HIV drugs, Emtriva and Reyataz
Two new HIV drugs, Emtriva and Reyataz, will help simplify drug regimens...because they're each given just ONCE a day.
Emtriva (emtricitabine) is a nucleoside analogue...similar to lamivudine (Epivir).
Emtriva is well-tolerated. It DOESN'T affect cytochrome P450 enzymes...therefore drug interactions aren't likely.